Harvard Bioscience
HBIO
HBIO
56 hedge funds and large institutions have $73.8M invested in Harvard Bioscience in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less capital invested
Capital invested by funds: $80.6M → $73.8M (-$6.85M)
Holders
56
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.72M | |
| 2 | +$1.31M | |
| 3 | +$245K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$166K |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$126K |
Top Sellers
| 1 | -$1M | |
| 2 | -$212K | |
| 3 | -$200K | |
| 4 |
Millennium Management
New York
|
-$108K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$106K |